Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.

MLA

Altrichter, Sabine, et al. “Benralizumab Does Not Elicit Therapeutic Effect in Patients with Chronic Spontaneous Urticaria: Results from the Phase IIb Multinational Randomized Double-Blind Placebo-Controlled ARROYO Trial.” The British Journal of Dermatology, vol. 191, no. 2, July 2024, pp. 187–99. EBSCOhost, https://doi.org/10.1093/bjd/ljae067.

APA

Altrichter, S., Giménez-Arnau, A. M., Bernstein, J. A., Metz, M., Bahadori, L., Bergquist, M., Brooks, L., Ho, C. N., Jain, P., Lukka, P. B., Rodriguez-Suárez, E., Walton, C., & Datto, C. J. (2024). Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. The British Journal of Dermatology, 191(2), 187–199. https://doi.org/10.1093/bjd/ljae067

Chicago

Altrichter, Sabine, Ana Maria Giménez-Arnau, Jonathan A Bernstein, Martin Metz, Lila Bahadori, Maria Bergquist, Laura Brooks, et al. 2024. “Benralizumab Does Not Elicit Therapeutic Effect in Patients with Chronic Spontaneous Urticaria: Results from the Phase IIb Multinational Randomized Double-Blind Placebo-Controlled ARROYO Trial.” The British Journal of Dermatology 191 (2): 187–99. doi:10.1093/bjd/ljae067.